Summary
Despite numerous studies on the topic, there is no consensus to date on the effects of oral contraceptives on mood or the mechanism(s) by which they exert these effects. This review article presents a theoretical model to explain the way in which oral contraceptives may affect mood. Specifically, it is argued that progestins exert differential effects on endogenous levels of neurosteroids, thereby altering mood. After providing an overview of the effects of estrogen, progesterone, and progesterone’s metabolites on cortical excitabilityand the role of neurosteroids in depression and premenstrual dysphoria, this article reviews the research that has been conducted on the relationship between oral contraceptives and neurosteroids. Finally, suggestions for future research are made with the dual aim of improving existing studies on the relationship between oral contraceptives and mood and further investigating the possibility that fluctuations in neurosteroid levels are responsible for the effects of oral contraceptives on mood.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
S Abraham G Luscombe I Soo (2003) ArticleTitleOral contraception and cyclic changes in premenstrual and menstrual experiences. J Psychosom Obstet Gynaecol 24 IssueID3 185–193 Occurrence Handle1:STN:280:DC%2BD3srgvVeltg%3D%3D Occurrence Handle14584305 Occurrence Handle10.3109/01674820309039672
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. Washington, D.C.
FD Anderson H Hait InstitutionalAuthorNameThe Seasonale 301 Study Group (2003) ArticleTitleA multicenter, randomized study of an extended cycle oral contraceptive. Contraception 68 89–96 Occurrence Handle10.1016/S0010-7824(03)00141-0 Occurrence Handle1:CAS:528:DC%2BD3sXmvVyhsLk%3D Occurrence Handle12954519
D Apter A Borsos W Baumgartner G-B Melis D Vexiau-Robert A Colligs-Hakert et al. (2003) ArticleTitleEffect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms. Eur J Contracept Reprod Health Care 8 37–51 Occurrence Handle1:CAS:528:DC%2BD3sXjtlygtbo%3D Occurrence Handle12725674
J Bancroft D Sanders P Warner N Loudon (1987) ArticleTitleThe effects of oral contraceptives on mood and sexuality: a comparison of triphasic and combined preparations. J Psychosom Obstet Gynecol 7 1–8
R Bergeron C de Montigny G Debonnel (1996) ArticleTitlePotentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci 16 1193–1202 Occurrence Handle1:CAS:528:DyaK28XmsVersA%3D%3D Occurrence Handle8558248
CL Bethea M Pecins-Thompson WE Schutzer C Gundlah ZN Lu (1998) ArticleTitleOvarian steroids and serotonin neural function. Mol Neurobiol 18 87–123 Occurrence Handle1:CAS:528:DyaK1MXhsV2rtr0%3D Occurrence Handle10065876 Occurrence Handle10.1007/BF02914268
D Bitran RJ Hilvers CK Kellogg (1991) ArticleTitleAnxiolytic effects of 3 alpha-hydroxy-5 alpha [beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res 561 157–161 Occurrence Handle10.1016/0006-8993(91)90761-J Occurrence Handle1:CAS:528:DyaK3MXmslSqt7s%3D Occurrence Handle1686744
J Borenstein Y Hsing-Ting S Wade C-F Chiou A Rapkin (2003) ArticleTitleEffect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life. J Reprod Med 48 79–85 Occurrence Handle1:CAS:528:DC%2BD3sXit1Git70%3D Occurrence Handle12621790
MD Brot Y Akwa RH Purdy GF Koob KT Britton (1997) ArticleTitleThe anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABAA receptors. Eur J Pharmacol 325 1–7 Occurrence Handle10.1016/S0014-2999(97)00096-4 Occurrence Handle1:CAS:528:DyaK2sXivFyntLY%3D Occurrence Handle9151931
TJ Brown B Scherz RB Hochberg NJ MacLusky (1996) ArticleTitleRegulation of estrogen receptor concentrations in the rat brain: effects of sustained androgen and estrogen exposure. Neuroendocrinology 63 53–60 Occurrence Handle1:CAS:528:DyaK28XotFCiuw%3D%3D Occurrence Handle8839355
C Brown F Ling J Wan (2001) ArticleTitleEffect of a new monophasic oral contraceptive on perimenstrual symptoms [abstract]. Obstetr Gynecol 97S 9
V Bruni H Croxatto J De La Cruz M Dhont F Durlot MTMS Fernandes et al. (2000) ArticleTitleA comparison of cycle control and effects on well-being of monophasic gestodene, triphasic gestodene, and monophasic desogestrel-containing oral contraceptives. Gynecol Endocrinol 14 90–98 Occurrence Handle1:STN:280:DC%2BD3cvhs1Wltg%3D%3D Occurrence Handle10836195 Occurrence Handle10.3109/09513590009167666
K Carlstrom R Karlsson B Von Schoultz (2002) ArticleTitleDiurnal rhythm and effects of oral contraceptives on serum dehydroepiandrosterone sulfate (DHEAS) are related to alterations in serum albumin rather than to changes in adrenocortical steroid secretion. Scand J Clin Lab Invest 62 361–368 Occurrence Handle1:STN:280:DC%2BD38nivFOgsw%3D%3D Occurrence Handle12387582
BR Carr (1998) ArticleTitleUniqueness of Oral Contraceptive Progestins. Contraception 58 23S–27S Occurrence Handle10.1016/S0010-7824(98)00079-1 Occurrence Handle1:CAS:528:DyaK1cXnt1Kmtrs%3D Occurrence Handle9807689
J Cullberg (1972) ArticleTitleMood changes and menstrual symptoms with different gestagen/estrogen combinations. Acta Psychiatr Scand 236 1–72 Occurrence Handle1:STN:280:DyaE3s%2Fls1eruw%3D%3D
JB Deijen KJ Duyn WA Jansen JW Klitsie (1992) ArticleTitleUse of a monophasic, low-dose oral contraceptive in relation to mental functioning. Contraception 46 359–367 Occurrence Handle10.1016/0010-7824(92)90098-E Occurrence Handle1:STN:280:DyaK3s7jslGksA%3D%3D Occurrence Handle1486774
C Egarter MA Topcuoglu M Imhof J Huber (1999) ArticleTitleLow dose oral contraceptives and quality of life. Contraception 59 287–291 Occurrence Handle10.1016/S0010-7824(99)00040-2 Occurrence Handle1:STN:280:DyaK1MvisValug%3D%3D Occurrence Handle10494481
CN Epperson KL Wisner B Yamamoto (1999) ArticleTitleGonadal steroids in the treatment of mood disorders. Psychosom Med 61 676–697 Occurrence Handle1:CAS:528:DyaK1MXmslGhsrk%3D Occurrence Handle10511016
CN Epperson K Haga G Mason E Sellers R Gueorguivea W Zhang et al. (2002) ArticleTitleCortical γ-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder. Arch Gen Psychiatry 59 851–858 Occurrence Handle1:CAS:528:DC%2BD38Xns1anuro%3D Occurrence Handle12215085
E Eriksson C Sundblad P Lisjo K Modigh B Andersch (1992) ArticleTitleSerum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology 17 195–204 Occurrence Handle10.1016/0306-4530(92)90058-F Occurrence Handle1:STN:280:DyaK3s%2Fms1ygtQ%3D%3D Occurrence Handle1438645
U Ernst L Baumgartner U Bauer G Janssen (2002) ArticleTitleImprovement in quality of life in women using a low-dose desogestrel-containing contraceptive: results of an observational clinical evaluation. Eur J Contracep Reprod Health Care 7 238–243 Occurrence Handle1:STN:280:DC%2BD3s7ktV2itw%3D%3D
J-M Foidart W Wuttke GM Bouw C Gerlinger R Heithecker (2000) ArticleTitleA comparative investigation of contraceptive reliability cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel. Eur J Contracept Reprod Health Care 5 124–134 Occurrence Handle1:CAS:528:DC%2BD3cXlslehtrc%3D Occurrence Handle10943575
P Follesa P Porcu C Sogliano M Cinus F Biggio L Mancuso et al. (2002) ArticleTitleChanges in GABAA receptor γ2 subunit gene expression induced by long-term administration of oral contraceptives in rats. Neuropharmacology 42 325–336 Occurrence Handle1:CAS:528:DC%2BD38XhvVCjs7g%3D Occurrence Handle11897111
EW Freeman R Kroll A Rapkin T Pearlstein C Brown K Parsey et al. (2001) ArticleTitleEvaluation of a unique oral contraceptive in the treatment of Premenstrual Dysphoric Disorder. J Womens Health Gender Based Med 10 IssueID6 561–569 Occurrence Handle1:STN:280:DC%2BD3MrhtVKitQ%3D%3D
EW Freeman CA Frye K Rickels PA Martin SS Smith (2002) ArticleTitleAllopregnanolone levels and symptom improvement in severe premenstrual syndrome. J Clin Psychopharmacol 22 516–520 Occurrence Handle10.1097/00004714-200210000-00013 Occurrence Handle1:CAS:528:DC%2BD38Xntl2jtro%3D Occurrence Handle12352277
U Fuhrmann R Krattenmacher EP Slater KH Fritzemeier (1996) ArticleTitleThe novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential. Contraception 54 243–251 Occurrence Handle10.1016/S0010-7824(96)00195-3 Occurrence Handle1:CAS:528:DyaK28Xnt1aqt7o%3D Occurrence Handle8922878
SS Girdler PA Straneva KC Light CA Pedersen AL Morrow (2001) ArticleTitleAllopregnanolone levels and reactivity to mental stress in Premenstrual Dysphoric Disorder. Biol Psychiatry 49 788–797 Occurrence Handle10.1016/S0006-3223(00)01044-1 Occurrence Handle1:CAS:528:DC%2BD3MXivFejurk%3D Occurrence Handle11331087
CA Graham BB Sherwin (1992) ArticleTitleA prospective treatment of premenstrual syndrome using a triphasic oral contraceptive. J Psychosom Res 36 257–266 Occurrence Handle10.1016/0022-3999(92)90090-O Occurrence Handle1:STN:280:DyaK383islSisA%3D%3D Occurrence Handle1564678
CA Graham BB Sherwin (1993) ArticleTitleThe relationship between mood and sexuality in women using an oral contraceptive as treatment for premenstrual syndrome. Psychoneuroendocrinology 18 273–281 Occurrence Handle1:STN:280:DyaK3szgtlamsQ%3D%3D Occurrence Handle8316616
I Gureviciene J Puolivali R Pussinen J Wang H Tanila A Ylinen (2003) ArticleTitleEstrogen treatment alleviates NMDA-antagonist induced hippocampal LTP blockade and cognitive deficits in ovariectomized mice. Neurobiol Learn Mem 79 IssueID1 72–80 Occurrence Handle10.1016/S1074-7427(02)00012-6 Occurrence Handle1:CAS:528:DC%2BD38Xps1SjsLo%3D Occurrence Handle12482681
JN Gutmann SL Corson (1994) ArticleTitleThe new progestins: pharmacologic and clinical aspects. Int J Fertil 39 IssueIDS3 163–176
J Huber JM Foidart W Wuttke GS Merki-Feld HS The C Gerlinger et al. (2000) ArticleTitleEfficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone. Eur J Contracept Reprod Health Care 5 25–34 Occurrence Handle1:CAS:528:DC%2BD3cXktFCksbs%3D Occurrence Handle10836660
H Joffe LS Cohen BL Harlow (2003) ArticleTitleImpact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration. Obstet Gynecol 189 1523–1530 Occurrence Handle1:CAS:528:DC%2BD2cXpvF2ntA%3D%3D
A Kugaya CN Epperson S Zoghbi CH van Dyck Y Hou M Fujita et al. (2003) ArticleTitleIncrease in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 160 1522–1524 Occurrence Handle10.1176/appi.ajp.160.8.1522 Occurrence Handle12900319
J Leeton (1974) ArticleTitleDepression induced by oral contraception and the role of vitamin B6 in its management. Aust N Z J Psychiatry 8 85–88 Occurrence Handle1:STN:280:DyaE2M%2FgvVKhug%3D%3D Occurrence Handle4547177 Occurrence Handle10.3109/00048677409159781
RA Lobo FZ Stanczyk (1994) ArticleTitleThe role of hormonal contraceptives: new knowledge in the physiology of hormonal contraceptives. Am J Obstet Gynecol 170 IssueID5S 1499–1507 Occurrence Handle1:CAS:528:DyaK2cXmslaiu7Y%3D Occurrence Handle8178898
MD Majewska (1987) ArticleTitleSteroids and brain activity. Essential dialogue between body and mind. Biochem Pharmacol 36 3781–3788 Occurrence Handle10.1016/0006-2952(87)90437-0 Occurrence Handle1:CAS:528:DyaL1cXkvFeksA%3D%3D Occurrence Handle2825703
MD Majewska J-M Mienville S Vicini (1988) ArticleTitleNeurosteroid pregnanolone sulfate antagonizes electrophysiological responses to GABA in neurons. Neurosci Lett 90 279–284 Occurrence Handle10.1016/0304-3940(88)90202-9 Occurrence Handle1:CAS:528:DyaL1cXkvVKmsbw%3D Occurrence Handle3138576
MD Majewska S Demirgoren CE Spivak ED London (1990) ArticleTitleThe neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res 526 143–146 Occurrence Handle10.1016/0006-8993(90)90261-9 Occurrence Handle1:CAS:528:DyaK3cXls1Glt7Y%3D Occurrence Handle1964106
BS McEwen SE Alves (1999) ArticleTitleEstrogen actions in the central nervous system. Endocr Rev 20 279–307 Occurrence Handle10.1210/er.20.3.279 Occurrence Handle1:CAS:528:DyaK1MXktVaqtL0%3D Occurrence Handle10368772
FP Monnet V Mahe P Robel E-E Baulieu (1995) ArticleTitleNeurosteroids, via σ receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci 92 3774–3778 Occurrence Handle1:CAS:528:DyaK2MXlsVSlurw%3D Occurrence Handle7731982
P Monteleone S Luisi A Tonetti F Bernardi AD Genazzani M Luisi et al. (2000) ArticleTitleAllopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 142 269–273 Occurrence Handle10.1530/eje.0.1420269 Occurrence Handle1:CAS:528:DC%2BD3cXitlCrsLs%3D Occurrence Handle10700721
M Morrell (1999) ArticleTitleEpilepsy in women: the science of why it is special. Neurology 53 IssueIDS1 S42–S48 Occurrence Handle1:CAS:528:DyaK1MXmsVajs70%3D Occurrence Handle10487515
DD Murphy NB Cole V Greenberger M Segal (1998) ArticleTitleEstradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J Neurosci 18 IssueID7 2550–2559 Occurrence Handle1:CAS:528:DyaK1cXitFCjs7w%3D Occurrence Handle9502814
KA Oinonen D Mazmanian (2002) ArticleTitleTo what extent do oral contraceptives influence mood and affect? J Affect Disord 70 229–240 Occurrence Handle10.1016/S0165-0327(01)00356-1 Occurrence Handle1:CAS:528:DC%2BD38XlsVOru7o%3D Occurrence Handle12128235
AM Paoletti S Lello S Fratta M Orru F Ranuzzi C Sogliano et al. (2004) ArticleTitlePsychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 µg of ethinyl estradiol. Fertili Steril 81 645–651 Occurrence Handle1:CAS:528:DC%2BD2MXitFCrtrw%3D
KS Parsey A Pong (2000) ArticleTitleAn open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen. Contraception 61 105–111 Occurrence Handle10.1016/S0010-7824(00)00083-4 Occurrence Handle1:CAS:528:DC%2BD3cXjtVCisLk%3D Occurrence Handle10802275
M Pecins-Thompson NA Brown SG Kohama CL Bethea (1996) ArticleTitleOvarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J Neurosci 16 7021–7029 Occurrence Handle1:CAS:528:DyaK28Xntlegsbg%3D Occurrence Handle8824338
D Petitti (2003) ArticleTitleCombination estrogen-progestin oral contraceptives. N Engl J Med 349 1443–1450 Occurrence Handle10.1056/NEJMcp030751 Occurrence Handle1:CAS:528:DC%2BD3sXotVGgsLY%3D Occurrence Handle14534338
A Phillips K Demarest DW Hahn F Wong JL McGuire (1990) ArticleTitleProgestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins. Contraception 41 399–410 Occurrence Handle10.1016/0010-7824(90)90039-X Occurrence Handle1:CAS:528:DyaK3cXktFOqtbY%3D Occurrence Handle2335104
AJ Rapkin M Morgan L Goldman DW Brann D Simone VB Mahesh (1997) ArticleTitleProgesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 90 709–714 Occurrence Handle10.1016/S0029-7844(97)00417-1 Occurrence Handle1:STN:280:DyaK1c%2Fht1Witg%3D%3D Occurrence Handle9351749
SL Rosenthal S Cotton JN Ready LS Potter PA Succop (2002) ArticleTitleAdolescents’ attitudes and experiences regarding levonorgestrel 100 mcg/ethinyl estradiol 20 mcg. J Pediatr Adolesc Gynecol 15 301–305 Occurrence Handle10.1016/S1083-3188(02)00196-1 Occurrence Handle1:STN:280:DC%2BD3s%2FktVaqtg%3D%3D Occurrence Handle12547661
SA Sanders CA Graham JL Bass J Bancroft (2001) ArticleTitleA prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 64 51–58 Occurrence Handle10.1016/S0010-7824(01)00218-9 Occurrence Handle1:STN:280:DC%2BD3Mvpt12rsg%3D%3D Occurrence Handle11535214
M Sangthawan S Taneepanichskul (2005) ArticleTitleA comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 µg on premenstrual symptoms. Contraception 71 1–7 Occurrence Handle10.1016/j.contraception.2004.07.010 Occurrence Handle1:CAS:528:DC%2BD2MXnvFOr Occurrence Handle15639064
PJ Schmidt RH Purdy PH Moore SuffixJr SM Paul DR Rubinow (1994) ArticleTitleCirculating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metabol 79 1256–1260 Occurrence Handle10.1210/jc.79.5.1256 Occurrence Handle1:CAS:528:DyaK2MXit1eks74%3D
PJ Schmidt LK Nieman MA Danaceau LF Adams DR Rubinow (1998) ArticleTitleDifferential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338 209–216 Occurrence Handle10.1056/NEJM199801223380401 Occurrence Handle1:CAS:528:DyaK1cXosVeqsA%3D%3D Occurrence Handle9435325
M Sillem R Schneidereit R Heithecker AO Mueck (2003) ArticleTitleUse of an oral contraceptive containing drospirenone in an extended regimen. Eur J Contracept Reprod Health Care 8 162–169 Occurrence Handle1:CAS:528:DC%2BD3sXpvFShtbg%3D Occurrence Handle14667328 Occurrence Handle10.1080/713604447
B Simic J Kniewald Z Kniewald (1998) ArticleTitleInfluence of ethynodiol diacetate on the formation of A-Homo-3-Oxa-5α-Pregnane-4,20-dione in female rats. Endocr Regul 32 125–131 Occurrence Handle1:CAS:528:DyaK1MXht1yju7c%3D Occurrence Handle10196509
MJ Smith LF Adams PJ Schmidt DR Rubinow EM Wasserman (2003) ArticleTitleAbnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome. Biol Psychiatry 54 757–762 Occurrence Handle1:CAS:528:DC%2BD3sXnsVKlsbc%3D Occurrence Handle14512217
M Steiner E Dunn L Born (2003) ArticleTitleHormones and mood: from menarche to menopause and beyond. J Affect Disord 74 67–83 Occurrence Handle10.1016/S0165-0327(02)00432-9 Occurrence Handle1:CAS:528:DC%2BD3sXitFanur8%3D Occurrence Handle12646300
PJ Sulak RD Scow C Preece MW Riggs TJ Kuehl (2000) ArticleTitleHormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 95 261–266 Occurrence Handle10.1016/S0029-7844(99)00524-4 Occurrence Handle1:CAS:528:DC%2BD3cXltVaksA%3D%3D Occurrence Handle10674591
BEH Sumner G Fink (1993) ArticleTitleEffects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain. Mol Cell Neurosci 4 83–92 Occurrence Handle10.1006/mcne.1993.1010 Occurrence Handle1:CAS:528:DyaK3sXitVGnt7s%3D Occurrence Handle19912911
BEH Sumner G Fink (1995) ArticleTitleEstrogen increases the density of 5-hydroxytryptamine2A receptors in cerebral cortex and nucleus accumbens in the female rat. J Steroid Biochem Mol Biol 54 15–20 Occurrence Handle10.1016/0960-0760(95)00075-B Occurrence Handle1:CAS:528:DyaK2MXnt1yhtLY%3D
I Sundstrom A Andersson S Nyberg D Ashbrook RH Purdy T Backstrom (1998) ArticleTitlePatients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 67 126–138 Occurrence Handle1:STN:280:DyaK1c7mslClsA%3D%3D Occurrence Handle9508043
H Sveindottir T Backstrom (2000) ArticleTitlePrevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives. Acta Obstet Gynecol Scand 79 405–413 Occurrence Handle10.1034/j.1600-0412.2000.079005405.x Occurrence Handle1:STN:280:DC%2BD3c3ovFKitw%3D%3D Occurrence Handle10830769
M Vallee JD Rivera GF Koob RH Purdy RL Fitzgerald (2000) ArticleTitleQuantification of neurosteroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography/mass spectrometry. Anal Biochem 287 153–166 Occurrence Handle10.1006/abio.2000.4841 Occurrence Handle1:CAS:528:DC%2BD3cXotVCgsr8%3D Occurrence Handle11078595
F Winston (1973) ArticleTitleOral contraceptives, pyridoxine, and depression. Am J Psychiatry 130 1217–1221 Occurrence Handle1:CAS:528:DyaE2cXit1yktQ%3D%3D Occurrence Handle4795720
M Wang L Seippel RH Purdy T Backstrom (1996) ArticleTitleRelationship between symptom severity and steroid variation in women with Premenstrual Syndrome: Study on serum pregnenolone, pregnenolone sulfate, 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnan-20-one. J Clin Endocrinol Metabol 81 1076–1082 Occurrence Handle1:CAS:528:DyaK28Xhs1agsLc%3D
S Wieland NC Lan S Mirasedeghi KW Gee (1991) ArticleTitleAnxiolytic activity of the progesterone metabolite 5 alpha-pregnan-3 alpha-o1-20-one. Brain Res 565 263–268 Occurrence Handle10.1016/0006-8993(91)91658-N Occurrence Handle1:CAS:528:DyaK38Xns1Gqtg%3D%3D Occurrence Handle1688192
YH Wimberly S Cotton AM Wanchick PA Succop SL Rosenthal (2002) ArticleTitleAttitudes and experiences with levonorgestrel 100 µg/ethinyl estradiol 20 µg among women during a 3-month trial. Contraception 65 403–406 Occurrence Handle10.1016/S0010-7824(02)00314-1 Occurrence Handle1:CAS:528:DC%2BD38XlsVKrtbY%3D Occurrence Handle12127637
UH Winkler H Ferguson JAPA Mulders (2004) ArticleTitleCycle control, quality of life, and acne with two low-dose oral contraceptives containing 20 µg ethinylestradiol. Contraception 69 469–476 Occurrence Handle10.1016/j.contraception.2003.12.017 Occurrence Handle1:CAS:528:DC%2BD2cXkt1SlurY%3D Occurrence Handle15157791
P Wise D Dubal M Wilson et al. (2001) ArticleTitleMini review: neuroprotective effects of estrogen-new insights into mechanisms of action. Endocrinology 142 969–973 Occurrence Handle10.1210/en.142.3.969 Occurrence Handle1:CAS:528:DC%2BD3MXhsFemsb8%3D Occurrence Handle11181507
M Wong TL Thompson RL Moss (1996) ArticleTitleNongenomic actions of estrogen in the brain: Physiological significance and cellular mechanisms. Crit Rev Neurobiol 10 189–203 Occurrence Handle1:CAS:528:DyaK2sXksl2isg%3D%3D Occurrence Handle8971129
CS Woolley (1999) ArticleTitleElectrophysiological and cellular effects of estrogen on neuronal function. Crit Rev Neurobiol 13 1–20 Occurrence Handle1:CAS:528:DyaK1MXitlygsrY%3D Occurrence Handle10223521
MR Zamani WB Levy NL Desmond (2004) ArticleTitleEstradiol increases delayed, N-methyl-D-aspartate receptor-mediated excitation in the hippocampal CA1 region. Neuroscience 129 IssueID1 243–254 Occurrence Handle10.1016/j.neuroscience.2004.06.082 Occurrence Handle1:CAS:528:DC%2BD2cXos1yku70%3D Occurrence Handle15489046
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kurshan, N., Neill Epperson, C. Oral contraceptives and mood in women with and without premenstrual dysphoria: a theoretical model. Arch Womens Ment Health 9, 1–14 (2006). https://doi.org/10.1007/s00737-005-0102-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00737-005-0102-z